Suppr超能文献

组织因子途径抑制剂在人血浆中的抗凝活性优先与低密度脂蛋白和高密度脂蛋白的致密亚类以及脂蛋白(a)相关。

Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a).

作者信息

Lesnik P, Vonica A, Guérin M, Moreau M, Chapman M J

机构信息

Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.

出版信息

Arterioscler Thromb. 1993 Jul;13(7):1066-75. doi: 10.1161/01.atv.13.7.1066.

Abstract

Human plasma contains a multivalent, Kunitz-type proteinase inhibitor termed tissue factor pathway inhibitor (TFPI), which specifically inhibits the action of the factor VII(a)-tissue factor complex in coagulation. In the present study, we examined the distribution and anticoagulant activity of TFPI among plasma lipoprotein subspecies separated by isopycnic density gradient ultracentrifugation; this procedure permitted the simultaneous fractionation of the major lipoprotein classes (very-low-density lipoprotein [VLDL], intermediate-density lipoprotein [IDL], low-density lipoprotein [LDL], high-density lipoprotein [HDL] 2 and 3, and very-high-density lipoprotein [VHDL]). Studies of eight normolipidemic subjects revealed two major lipoprotein carriers of TFPI activity: dense LDL subspecies (d = 1.039 to 1.063 g/mL) and both dense HDL particles and VHDL (d = 1.133 to 1.190 g/mL), representing 33.8% and 35.9%, respectively, of the total lipoprotein-associated TFPI activity in plasma. TFPI activity was also associated with lipoprotein(a) (Lp[a]), whose density distribution (d = 1.044 to 1.100 g/mL) overlapped that of LDL and HDL2; such association was related to Lp(a)'s particle size and phenotype. VLDL, IDL, and LDL1 through LDL3 (d = 1.019 to 1.039 g/mL), HDL2 (d = 1.063 to 1.100 g/mL), and light subfractions of HDL3 (d = 1.100 to 1.167 g/mL) conveyed only 1.8%, 10%, and 18.5%, respectively, of lipoprotein-associated TFPI activity. Such anticoagulant activity was dependent on the presence of TFPI protein. The dense subspecies of HDL3 (d = 1.133 to 1.167 g/mL) with which TFPI was preferentially associated were small, displayed a cholesteryl ester to protein ratio of approximately 0.2, and were deficient in phospholipid (13.6% to 18.3%). HDL subspecies of d = 1.110 to 1.167 g/mL mainly contained the higher relative molecular mass form of TFPI of 41 kD (a form that is known to be covalently associated with apolipoprotein [apo] A-II) and minor bands of the 35- and 52-kD forms. The second major localization of TFPI was within the hydrated density range of small, dense LDL particles (d = 1.033 to 1.063 g/mL), which in comparison with light LDL (d = 1.019 to 1.033 g/mL) exhibited a markedly lower proportion of triglyceride and enrichment in cholesteryl ester.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

人血浆中含有一种多价的、库尼茨型蛋白酶抑制剂,称为组织因子途径抑制剂(TFPI),它能特异性抑制凝血过程中因子VII(a)-组织因子复合物的作用。在本研究中,我们检测了通过等密度梯度超速离心分离的血浆脂蛋白亚类中TFPI的分布和抗凝活性;该方法可同时分离主要的脂蛋白类别(极低密度脂蛋白[VLDL]、中间密度脂蛋白[IDL]、低密度脂蛋白[LDL]、高密度脂蛋白[HDL]2和3以及极高密度脂蛋白[VHDL])。对8名血脂正常受试者的研究显示,TFPI活性有两种主要的脂蛋白载体:致密LDL亚类(密度d = 1.039至1.063 g/mL)以及致密HDL颗粒和VHDL(密度d = 1.133至1.190 g/mL),分别占血浆中与脂蛋白相关的TFPI活性总量的33.8%和35.9%。TFPI活性也与脂蛋白(a) [Lp(a)]相关,其密度分布(密度d = 1.044至1.100 g/mL)与LDL和HDL2重叠;这种关联与Lp(a)的颗粒大小和表型有关。VLDL、IDL以及LDL1至LDL3(密度d = 1.019至1.039 g/mL)、HDL2(密度d = 1.063至1.100 g/mL)和HDL3的轻亚组分(密度d = 1.100至1.167 g/mL)分别仅携带1.8%、10%和18.5%的与脂蛋白相关的TFPI活性。这种抗凝活性依赖于TFPI蛋白的存在。与TFPI优先相关的HDL3致密亚类(密度d = 1.133至1.167 g/mL)体积小,胆固醇酯与蛋白质的比例约为0.2,且磷脂含量不足(13.6%至18.3%)。密度d = 1.110至1.167 g/mL的HDL亚类主要含有相对分子质量较高的41 kD形式的TFPI(已知该形式与载脂蛋白[apo] A-II共价结合)以及35 kD和52 kD形式的少量条带。TFPI的第二个主要定位在小而致密的LDL颗粒的水合密度范围内(密度d = 1.033至1.063 g/mL),与轻LDL(密度d = 1.019至1.033 g/mL)相比,其甘油三酯比例明显较低,胆固醇酯含量丰富。(摘要截短至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验